Phenylephrine Hydrochloride
16 NDCs across 14 manufacturers|15 Generic,1 Brand
Phenylephrine Hydrochloride is used to treat fissure in ano, open-angle glaucoma, hemorrhoids, hypotension, pruritus ani and vasomotor rhinitis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Dec 20, 2012, and the first generic was approved Apr 27, 2018.
Phenylephrine Hydrochloride is available as 16 NDCs from 14 manufacturers (15 generic, 1 brand), with NADAC prices from $0.06 to $9.29 per ML — the most expensive product costs about 149× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
16
15G / 1B
Manufacturers
14
competing in market
Price Spread
$0.06 – $9.29
per ML
7d Activity
avg +0.3% WoW · of 16 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Paragon BioTeck, Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
alpha-1 Adrenergic Agonist class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
14 manufacturers producing PHENYLEPHRINE HYDROCHLORIDE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
PHENYLEPHRINE 2.5% EYE DROP | $9.2924 per ML | +1.00% |
PHENYLEPHRINE 2.5% EYE DROP | $9.2924 per ML | +1.00% |
PHENYLEPHRINE 2.5% EYE DROP | $9.2924 per ML | +1.00% |
PHENYLEPHRINE 2.5% EYE DROP | $9.2924 per ML | +1.00% |
PHENYLEPHRINE 2.5% EYE DROP | $9.2924 per ML | +1.00% |
PHENYLEPHRINE 2.5% EYE DROP | $9.2924 per ML | +1.00% |
PHENYLEPHRINE 2.5% EYE DROP | $9.2924 per ML | +1.00% |
PHENYLEPHRINE 10% EYE DROP | $5.2383 per ML | +2.08% |
PHENYLEPHRINE 2.5% EYE DROP | $1.0784 per ML | — |
4 WAY 1% NASAL SPRAY | $0.1920 per ML | — |
GNP NASAL FOUR 1% NASAL SPRAY | $0.0842 per ML | — |
QC NASAL SPRAY 1% | $0.0703 per ML | +1.11% |
SINUS RELIEF 1% NASAL SPRAY | $0.0703 per ML | +1.11% |
GS NASAL FOUR 1% NASAL SPRAY | $0.0672 per ML | -8.00% |
NASAL SPRAY 1% | $0.0650 per ML | — |
NASAL FOUR 1% NASAL SPRAY | $0.0623 per ML | — |
Frequently Asked Questions
What is Phenylephrine Hydrochloride used to treat?
Phenylephrine Hydrochloride is used to treat fissure in ano, open-angle glaucoma, hemorrhoids, hypotension, pruritus ani and vasomotor rhinitis, per the National Library of Medicine's MED-RT classification.
When did Phenylephrine Hydrochloride become available as a generic?
FDA approved the first generic Phenylephrine Hydrochloride (ANDA) on Apr 27, 2018.
How many Phenylephrine Hydrochloride products are on the market?
The Phenylephrine Hydrochloride drug market contains 16 NDCs from 14 manufacturers — 15 generic and 1 brand product.
What is the price range for Phenylephrine Hydrochloride?
NADAC reference prices for Phenylephrine Hydrochloride range from $0.0623 to $9.2924 per ML — the most expensive product costs about 149× the cheapest.
Is generic Phenylephrine Hydrochloride cheaper than brand?
The average generic NADAC for Phenylephrine Hydrochloride is $4.7855 per ML, versus $0.1920 for brand-labeled products — brand is currently about 96% cheaper on average.
Which manufacturers make Phenylephrine Hydrochloride?
14 manufacturers list Phenylephrine Hydrochloride in NADAC. Ranked by number of NDCs, the largest are Paragon BioTeck, Inc. (2), AmerisourceBergen (2), Alcon Laboratories, Inc. (1), Caplin Steriles Limited (1), Leading Pharma, LLC (1).
How has the price of Phenylephrine Hydrochloride changed recently?
Over the past 7 days, 10 Phenylephrine Hydrochloride NDCs rose and 1 fell, with a market-wide average change of +0.3%.